-
1
المصدر: Novo Nordisk A/S SWOT Analysis. 4/2/2024, p1-7. 7p.
مصطلحات موضوعية: *MEDICAL supplies industry, *SWOT analysis
مصطلحات جغرافية: DENMARK
الشركة/الكيان: NOVO Nordisk A/S NVO
-
2دورية أكاديمية
المؤلفون: Butler, Javed1,2 (AUTHOR), Shah, Sanjiv J1,3 (AUTHOR), Petrie, Mark C4 (AUTHOR), Borlaug, Barry A5 (AUTHOR), Abildstrøm, Steen Z6 (AUTHOR), Davies, Melanie J7,8 (AUTHOR), Hovingh, G Kees6 (AUTHOR), Kitzman, Dalane W9 (AUTHOR), Møller, Daniél Vega6 (AUTHOR), Verma, Subodh10 (AUTHOR), Einfeldt, Mette Nygaard6 (AUTHOR), Lindegaard, Marie L6 (AUTHOR), Rasmussen, Søren6 (AUTHOR), Abhayaratna, Walter11 (AUTHOR), Ahmed, Fozia Z12 (AUTHOR), Ben-Gal, Tuvia13 (AUTHOR), Chopra, Vijay14 (AUTHOR), Ezekowitz, Justin A15 (AUTHOR), Fu, Michael16 (AUTHOR), Ito, Hiroshi17 (AUTHOR)
المصدر: Lancet. 4/27/2024, Vol. 403 Issue 10437, p1635-1648. 14p.
مصطلحات موضوعية: HEART failure, VENTRICULAR ejection fraction, OBESITY complications, SYSTOLIC blood pressure, TREATMENT effect heterogeneity, SEMAGLUTIDE
مصطلحات جغرافية: KANSAS City (Kan.)
الشركة/الكيان: NOVO Nordisk A/S NVO
-
3دورية
المؤلفون: Mayer, Colin (AUTHOR)
المصدر: Developing Leaders. 2024, Issue 43, p108-123. 16p. 2 Color Photographs, 2 Cartoon or Caricatures.
مصطلحات موضوعية: *STOCK ownership, *CORPORATE culture, *STOCKHOLDERS, *INDUSTRIAL relations, PEOPLE with diabetes
الشركة/الكيان: NOVO Nordisk A/S NVO
-
4دورية أكاديمية
المؤلفون: Russell-Jones, David1,2 (AUTHOR) davidrussell-jones@nhs.net, Babazono, Tetsuya3 (AUTHOR), Cailleteau, Roman4 (AUTHOR), Engberg, Susanne4 (AUTHOR), Irace, Concetta5 (AUTHOR), Kjaersgaard, Maiken Ina Siegismund6 (AUTHOR), Mathieu, Chantal7 (AUTHOR), Rosenstock, Julio8 (AUTHOR), Woo, Vincent9 (AUTHOR), Klonoff, David C10 (AUTHOR)
المصدر: Lancet. Nov2023, Vol. 402 Issue 10413, p1636-1647. 12p.
مصطلحات موضوعية: TYPE 1 diabetes, INSULIN aspart, INSULIN, HYPOGLYCEMIA
الشركة/الكيان: NOVO Nordisk A/S NVO
-
5
المصدر: Novo Nordisk A/S SWOT Analysis. 10/18/2023, p1-7. 7p.
مصطلحات موضوعية: *MEDICAL supplies industry, *SWOT analysis
مصطلحات جغرافية: DENMARK
الشركة/الكيان: NOVO Nordisk A/S NVO
-
6دورية أكاديمية
المؤلفون: Strand, Robert1 MrNordic@berkeley.edu
المصدر: California Management Review. May2024, Vol. 66 Issue 3, p5-26. 22p.
مصطلحات موضوعية: *CORPORATE sustainability, *STAKEHOLDER theory, *SUSTAINABLE development, *SOCIAL responsibility of business
مصطلحات جغرافية: SCANDINAVIA
الشركة/الكيان: NOVO Nordisk A/S NVO, ORSTED A/S
-
7دورية
المؤلفون: Caglio, Ariela1 ariela.caglio@sdabocconi.it, Quattrone, Paolo2 paolo.quattrone@manchester.ac.uk
المصدر: Strategic Finance. Nov2023, Vol. 105 Issue 5, p37-45. 9p.
مصطلحات موضوعية: *STOCKHOLDER wealth, *DISCLOSURE, *BUSINESS ethics, *BUSINESS communication, SUSTAINABLE development reporting, SUSTAINABILITY
الشركة/الكيان: NOVO Nordisk A/S NVO
-
8دورية
المؤلفون: HUANG, NELLIE S. (AUTHOR) Nellie.Huang@futurenet.com
المصدر: Kiplinger Personal Finance. Feb2024, Vol. 78 Issue 2, p38-38. 1p. 2 Charts.
مصطلحات موضوعية: *PERSONAL finance, *MANUFACTURING industries, *MEDICAL care, *STOCKS (Finance)
الشركة/الكيان: NOVO Nordisk A/S NVO, ELI Lilly & Co. LLY
-
9دورية أكاديمية
المؤلفون: Aroda, Vanita R1 (AUTHOR) varoda@bwh.harvard.edu, Aberle, Jens2 (AUTHOR), Bardtrum, Lars3 (AUTHOR), Christiansen, Erik3 (AUTHOR), Knop, Filip K4,5,6 (AUTHOR), Gabery, Sanaz3 (AUTHOR), Pedersen, Sue D7 (AUTHOR), Buse, John B8 (AUTHOR)
المصدر: Lancet. 8/26/2023, Vol. 402 Issue 10403, p693-704. 12p.
مصطلحات موضوعية: TYPE 2 diabetes, SEMAGLUTIDE, ADULTS, ORAL medication
الشركة/الكيان: NOVO Nordisk A/S NVO
-
10دورية أكاديمية
المؤلفون: Frias, Juan P1 (AUTHOR) jfrias@velocityclinical.com, Deenadayalan, Srikanth2 (AUTHOR), Erichsen, Lars2 (AUTHOR), Knop, Filip K3,4,5 (AUTHOR), Lingvay, Ildiko6 (AUTHOR), Macura, Stanislava2 (AUTHOR), Mathieu, Chantal7 (AUTHOR), Pedersen, Sue D8 (AUTHOR), Davies, Melanie9,10 (AUTHOR)
المصدر: Lancet. 8/26/2023, Vol. 402 Issue 10403, p720-730. 11p.
مصطلحات موضوعية: TYPE 2 diabetes, SEMAGLUTIDE, SODIUM-glucose cotransporter 2 inhibitors, BLOOD sugar, GLYCEMIC control
الشركة/الكيان: NOVO Nordisk A/S NVO